Peyronie's disease: A review

Journal of Urology

Volumn 169, Issue 4, 2003, Pages 1234-1241

  Gholami, Shahram S ^b   Gonzalez Cadavid, Nestor F ^b   Lin, Ching Shwun ^b   Rajfer, Jacob ^b   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Penile induration; Review literature

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ALPHA TOCOPHEROL; CALCIUM CHANNEL BLOCKING AGENT; COLCHICINE; COLLAGENASE; DEXAMETHASONE; FIBRIN; INTERFERON; LEVACECARNINE; LIDOCAINE; REACTIVE OXYGEN METABOLITE; STEROID; SUPEROXIDE DISMUTASE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; VERAPAMIL;

ALOPECIA; ANOREXIA; ATROPHY; CLINICAL TRIAL; CORPOREAL RUPTURE; DIARRHEA; DNA MICROARRAY; ECCHYMOSIS; EJACULATION DISORDER; ERECTILE DYSFUNCTION; EXTRACORPOREAL LITHOTRIPSY; FLU LIKE SYNDROME; FLUSHING; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; INCIDENCE; LIBIDO DISORDER; LIVER TOXICITY; MALE GENITAL SYSTEM SURGERY; NAUSEA; PATHOGENESIS; PENIS PROSTHESIS; PEYRONIE DISEASE; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN DISEASE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0037376707     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000053800.62741.fe     Document Type: Review

References (73)

1. Lindsay, M. B., Schain, D. M., Grambsch, P., Benson, R. C., Beard, C. M. and Kurkland, L. T.: The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol, 146: 1007, 1991
2. Braun, M., Wassmer, G., Klotz, T., Reifenrath, B., Mathers, M. and Engelmann, U.: Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res, 12: 305, 2000
3. Smith, B. H.: Subclinical Peyronie's disease. Am J Clin Pathol, 52: 385, 1969
4. Nyberg, L. M., Jr., Bias, W. B., Hochberg, M. C. and Walsh, P. C.: Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens. J Urol, 128: 48, 1982
5. Gelbard, M. K., Dorey, F. and James, K.: The natural history of Peyronie's disease. J Urol, 144: 1376, 1990
6. Lopez, J. A. and Jarow, J. P.: Penile vascular evaluation of men with Peyronie's disease. J Urol, 149: 53, 1993
7. Devine, C. J., Jr., Somers, K. D., Jordan, G. H. and Schlossberg, S. M.: Proposal: trauma as the cause of the Peyronie's lesion. J Urol, 157: 285, 1997
8. Jarow, J. P. and Lowe, F. C.: Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. J Urol, 158: 1388, 1997
9. Somers, K. D. and Dawson, D. M.: Fibrin deposition in Peyronie's disease plaque. J Urol, 157: 311, 1997
10. Schiavino, D., Sasso, F., Nucera, E., Alcini, E., Gulino, G., Milani, A. et al: Immunologic findings in Peyronie's disease: a controlled study. Urology, 50: 764, 1997
11. Stewart, S., Malto, M., Sandberg, L. and Colburn, K. K.: Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease. J Urol, 152: 105, 1994
12. Davis, C. J. Jr.: The microscopic pathology of Peyronie's disease. J Urol, 157: 282, 1997
13. Gelbard, M. K.: Dystrophic penile calcification in Peyronie's disease. J Urol, 139: 738, 1988
14. El-Sakka, A. I., Selph, C. A., Yen, T. S. B., Dahiya, R. and Lue, T. F.: The effect of surgical trauma on rat tunica albuginea. J Urol, 159: 1700, 1998
15. Bivalacqua, T. J., Diner, E. K., Novak, T. E., Vohra, Y., Sikka, S. C., Champion, H. C. et al: A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol, 163: 1992, 2000
16. El-Sakka, A. I., Hassan, M. U., Nunes, L., Bhatnagar, R. S., Yen, T. S. and Lue, T. F.: Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br J Urol, 81: 445, 1998
17. El-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R. and Lue, T. F.: Peyronie's disease is associated with an increase in transforming growth factor-β protein expression. J Urol, 158: 1391, 1997
18. Walker, G. A., Guerrero, I. A. and Leinwand, L. A.: Myofibroblasts: molecular crossdressers. Curr Top Dev Biol, 51: 91, 2001
19. Fukunaga, M., Ushigome, S. and Ishikawa, E.: Ossifying subcutaneous tumor with myofibroblastic differentiation: a variant of ossifying fibromyxoid tumor of soft parts? Pathol Int, 44: 727, 1994
20. Border, W. A. and Ruoslahti, E.: Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest, 90: 1, 1992
21. Ferrini, M. G., Vernet, D., Magee, T. R., Shahed, A., Qian, A., Rajfer, J. et al: Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide, 6: 283, 2002
22. Chatziantoniou, C., Boffa, J. J., Ardaillou, R. and Dussaule, J. C.: Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin. J Clin Invest, 101: 2780, 1998
23. Vernet, D., Ferrini, M. G., Valente, E. G., Magee, T. R., Bou-Gharios, G., Rajfer, J. et al: Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide, 7: 262, 2002
24. Artaza, J. N., Bhasin, S., Mallidis, C., Taylor, W., Ma, K. and Gonzalez-Cadavid, N. F.: Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol, 190: 170, 2002
25. Kirk, S., Oldham, J., Kambadur, R., Sharma, M., Dobbie, P. and Bass, J.: Myostatin regulation during skeletal muscle regeneration. J Cell Physiol, 184: 356, 2000
26. Mulhall, J. P., Thom, J., Lubrano, T. and Shankey, T. V.: Basic fibroblast growth factor expression in Peyronie's disease. J Urol, 165: 419, 2001
27. Gentile, V., Modesti, A., La Pera, G., Vasaturo, F., Modica, A., Prigiotti, G. et al: Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction. J Androl, 17: 96, 1996
28. Magee, T. R., Qian, A., Rajfer, J., Sander, F. C., Levine, L. A. and Gonzalez-Cadavid, N. F.: Gene expression profiles in the Peyronie's disease plaque. Urology, 59: 451, 2002
29. Nakase, T., Sugimoto, M., Sato, M., Kaneko, M., Tomita, T., Sugamoto, K. et al: Switch of osteonectin and osteopontin mRNA expression in the process of cartilage-to-bone transition during fracture repair. Acta Histochem, 100: 287, 1998
30. Lin, C. S., Lin, G., Wang, Z., Maddah, S. A. and Lue, T. F.: Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie's disease. Biochem Biophys Res Commun, 295: 1014, 2002
31. Ralph, D. J., Hughes, T., Lees, W. R. and Pryor, J. P.: Preoperative assessment of Peyronie's disease using colour Doppler sonography. Br J Urol, 69: 629, 1992
32. Jordan, G. H. and Angermeier, K. W.: Preoperative evaluation of erectile function with dynamic infusion cavernosometry/cavernosography in patients undergoing surgery for Peyronie's disease: correlation with postoperative results. J Urol, 150: 1138, 1993
33. Akkus, E., Carrier, S., Rehman, J., Breza, J., Kadioglu, A. and Lue, T. F.: Is colchicine effective in Peyronie's disease? A pilot study. Urology, 44: 291, 1994
34. Diegelmann, R. F. and Peterkofsky, B.: Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sci USA, 69: 892, 1972
35. Carson, C. C.: Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Tech Urol, 3: 135, 1997
36. Hasche-Klunder, R.: Treatment of peyronie's disease with paraaminobenzoacidic potassium (POTOBA). Urologe A, 17: 224, 1978
37. Ralph, D. J., Brooks, M. D., Bottazzo, G. F. and Pryor, J. P.: The treatment of Peyronie's disease with tamoxifen. Br J Urol, 70: 648, 1992
38. Colletta, A. A., Wakefield, L. M., Howell, F. V., van Roozendaal, K. E., Danielpour, D., Ebbs, S. R. et al: Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer, 62: 405, 1990
39. Biagiotti, G. and Cavallini, G.: Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU Int, 88: 63, 2001
40. Scott, W. W. and Scardino, P. L.: New concept in treatment of Peyronie's disease. South Med J, 41: 173, 1948
41. Winter, C. C. and Khanna, R.: Peyronie's disease: results with dermo-jet injection of dexamethasone. J Urol, 114: 898, 1975
42. Levine, L. A.: Treatment of Peyronie's disease with intralesional verapamil injection. J Urol, 158: 1395, 1997
43. Rehman, J., Benet, A. and Melman, A.: Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology, 51: 620, 1998
44. Roth, M., Eickelberg, O., Kohler, E., Erne, P. and Block, L. H.: Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci USA, 93: 5478, 1996
45. Gelbard, M. K., James, K., Riach, P. and Dorey, F.: Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol, 149: 56, 1993
46. Gustafson, H., Johansson, B. and Edsmyr, F.: Peyronie's disease: experience of local treatment with Orgotein. Eur Urol, 7: 346, 1981
47. Duncan, M. R., Berman, B. and Nseyo, U. O.: Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons -alpha, -beta and -gamma. Scand J Urol Nephrol, 25: 89, 1991
48. Judge, I. S. and Wisniewski, Z. S.: Intralesional interferon in the treatment of Peyronie's disease: a pilot study. Br J Urol, 79: 40, 1997
49. Wegner, H. E., Andresen, R., Knispel, H. H. and Miller, K.: Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease. Eur Urol, 32: 190, 1997
50. Montorsi, F., Salonia, A., Guazzoni, G., Barbieri, L., Colombo, R., Brausi, M. et al: Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results. J Androl, 21: 85, 2000
51. Abdel-Salam, Y., Budair, Z., Renner, C., Frede, T., Rassweiler, J., El-Annany, F. et al: Treatment of Peyronie's disease by extracorporeal shockwave therapy: evaluation of our preliminary results. J Endourol, 13: 549, 1999
52. Hamm, R., McLarty, E., Ashdown, J., Natale, S. and Dickinson, A.: Peyronie's disease-the Plymouth experience of extracorporeal shockwave treatment. BJU Int, 87: 849, 2001
53. Nesbit, R. M.: Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol, 93: 230, 1965
54. Pryor, J. P. and Fitzpatrick, J. M.: A new approach to the correction of the penile deformity in Peyronie's disease. J Urol, 122: 622, 1979
55. Ralph, D. J., Al-Akraa, M. and Pryor, J. P.: The Nesbit operation for Peyronie's disease: 16-year experience. J Urol, 154: 1362, 1995
56. Andrews, H. O., Al-Akraa, M., Pryor, J. P. and Ralph, D. J.: The Nesbit operation for Peyronie's disease: an analysis of the failures. BJU Int, 87: 658, 2001
57. Yachia, D.: Modified corporoplasty for the treatment of penile curvature. J Urol, 143: 80, 1990
58. Essed, E. and Schroeder, F. H.: New surgical treatment for Peyronie disease. Urology, 25: 582, 1985
59. Gholami, S. S. and Lue, T. F.: Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol, 167: 2066, 2002
60. Devine, C. J., Jr. and Horton, C. E.: Surgical treatment of Peyronie's disease with a dermal graff. J Urol, 111: 44, 1974
61. Gelbard, M. K. and Hayden, B.: Expanding contractures of the tunica albuginea due to Peyronie's disease with temporalis fascia free grafts. J Urol, 145: 772, 1991
62. El-Sakka, A. I., Rashwan, H. M. and Lue, T. F.: Venous patch graft for Peyronie's disease. Part II: outcome analysis. J Urol, 160: 2050, 1998
63. Montorsi, F., Salonia, A., Maga, T., Bua, L., Guazzoni, G., Barbieri, L. et al: Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. J Urol, 163: 1704, 2000
64. Adeniyi, A. A., Goorney, S. R., Pryor, J. P. and Ralph, D. J.: The Lue procedure: an analysis of the outcome in Peyronie's disease. BJU Int, 89: 404, 2002
65. Akkus, E., Ozkara, H., Alici, B., Demirkesen, O., Akaydin, A., Hattat, H. et al: Incision and venous patch graft in the surgical treatment of penile curvature in Peyronie's disease. Eur Urol, 40: 531, 2001
66. Kadioglu, A., Tefekli, A., Usta, M., Demirel, S. and Tellaloglu, S.: Surgical treatment of Peyronie's disease with incision and venous patch technique. Int J Impot Res, 11: 75, 1999
67. Yurkanin, J. P., Dean, R. and Wessells, H.: Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction. J Urol, 166: 1769, 2001
68. Knoll, L. D.: Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's disease. Urology, 57: 753, 2001
69. Leungwattanakij, S., Bivalacqua, T. J., Reddy, S. and Hellstrom, W. J.: Long-term follow-up on use of pericardial graft in the surgical management of Peyronie's disease. Int J Impot Res, 13: 183, 2001
70. Montague, D. K., Angermeier, K. W., Lakin, M. M. and Ingleright, B. J.: AMS 3-piece inflatable penile prosthesis implantation in men with Peyronie's disease: comparison of CX and Ultrex cylinders. J Urol, 156: 1633, 1996
71. Wilson, S. K., Cleves, M. A. and Delk, J. R., II: Long-term followup of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol, 165: 825, 2001
72. Montorsi, F., Salonia, A., Maga, T., Colombo, R., Cestari, A., Guazzoni, G. et al: Reconfiguration of the severely fibrotic penis with a penile implant. J Urol, 166: 1782, 2001
73. Lue, T. F., Gelbard, M. K., Gueglio, G. et al: Peyronie's disease. In: Proceedings of the First International Consultation on Erectile Dysfunction. Edited by A. W. G. Jarding, S. Khoury, F. Giuliano et al. Oxford: Health Publication Ltd., pp. 437-475, 2000